Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice Settings
In a diverse cohort across practice settings, receipt of ICI was associated with improved survival, regardless of facility type, race and ethnicity, or socioeconomic status. Efforts to provide ICI access to all eligible patients may improve outcomes.
Authors
- Mario Mendoza González
- Bassam Ghabach
- David E. Gerber (ORCID: https://orcid.org/0000-0002-7812-6741)
- Kari Teigen
- Krishti Sabloak
- Kalyani Narra
- Melissa Howell
- Mitchell S. von Itzstein
- Jialing Liu
- Matthew Lee
Institutions
- Texas Christian University (US)
- Texas College (US)
- JPS Health Network (US)
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1016/j.jtocrr.2026.100952
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00